These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9547739

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
    Ghio L, Fornaro G, Rossi P.
    J Clin Psychopharmacol; 2009 Aug; 29(4):391-2. PubMed ID: 19593182
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Malignant neuroleptic syndrome and hyponatremia associated with risperidone poisoning].
    Epelde Gonzalo F.
    An Med Interna; 2002 Jan; 19(1):50. PubMed ID: 11989083
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F, Geerlings CJ, Rietveld AP.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract] [Full Text] [Related]

  • 10. Neuroleptic Malignant Syndrome with ziprasidone.
    Murty RG, Mistry SG, Chacko RC.
    J Clin Psychopharmacol; 2002 Dec 15; 22(6):624-6. PubMed ID: 12454565
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Neuroleptic malignant syndrome in users of risperidone].
    Vorel SK, Bos F, Vorel-Havelkova E, Brombacher PJ.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):159-60; author reply 160. PubMed ID: 15693596
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011 Jan 15; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 18. [Neuroleptic malignant syndrome in users of risperidone].
    van Waarde JA, Kuiper J, Verwey B.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):156-7; author reply 157. PubMed ID: 15693593
    [No Abstract] [Full Text] [Related]

  • 19. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA, de Jonghe-Rouleau AP, Stienstra-Liem LH.
    Ned Tijdschr Geneeskd; 2004 Sep 11; 148(37):1801-4. PubMed ID: 15495506
    [Abstract] [Full Text] [Related]

  • 20. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report.
    Yamashita T, Fujii Y, Misawa F.
    J Clin Psychopharmacol; 2013 Feb 11; 33(1):127-9. PubMed ID: 23288234
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.